Table 4. Differential levels of CCL15 in various groups.

Groups	CCL15 (pg ml−1)
Cancer
B-related HCC (55)	26.6±1.2
C-related HCC (25)	23.9±3.1a
Lung cancer (15)	4.3±1.7b
Gastric cancer (15)	4.1±0.5c
Carcinoma of gallbladder (15)	3.6±1.5d
Benign diseases (65)	2.0±0.9e,f
Healthy controls (60)	1.2±0.1g

Abbreviations: CCL15=C-C motif chemokine 15; HCC=hepatocellular carcinoma.

^a Showed P>0.05 between B-related HCC and C-related HCC.

^b Showed P<0.05 between B-related HCC and lung cancer.

^c Showed P<0.05 between B-related HCC and gastric cancer.

^d Showed P<0.05 between B-related HCC and carcinoma of gallbladder.

^e Showed P<0.05 between B-related HCC and benign diseases.

^f Showed P>0.05 between benign diseases and healthy controls.

^g Showed P<0.05 between B-related HCC and healthy controls.